Overview
Kevin Weeks is an Oncologist and a Hematologist in Sequim, Washington. Dr. Weeks is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Sideroblastic Anemia, Myelodysplastic Syndrome (MDS), Richter Syndrome, and Chronic Lymphocytic Leukemia (CLL). Dr. Weeks is currently accepting new patients.
His clinical research consists of co-authoring 2 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
The Association Of University Physicians
Smitha Menon is a Hematologist and an Oncologist in Seattle, Washington. Dr. Menon is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.
Sid Devarakonda is an Oncologist in Seattle, Washington. Dr. Devarakonda has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Devarakonda is currently accepting new patients.
Franciscan Medical Group
Jacob Mathew is a Hematologist and an Oncologist in Bremerton, Washington. Dr. Mathew is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Pleuropulmonary Blastoma, Colorectal Cancer, and Bone Marrow Aspiration. Dr. Mathew is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Lymphocytic Leukemia (CLL)Dr. Weeks isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Colorectal CancerDr. Weeks isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Weeks isDistinguished. Learn about Familial Colorectal Cancer.
- Lung AdenocarcinomaDr. Weeks isDistinguished. Learn about Lung Adenocarcinoma.
- Lynch SyndromeDr. Weeks isDistinguished. Learn about Lynch Syndrome.
- Mantle Cell Lymphoma (MCL)Dr. Weeks isDistinguished. Learn about Mantle Cell Lymphoma (MCL).
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Weeks isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Weeks isAdvanced. Learn about Adult Immune Thrombocytopenia.
- ALK-Positive Non-Small Cell Lung Cancer
- Anal CancerDr. Weeks isAdvanced. Learn about Anal Cancer.
- Experienced
- Adenoid Cystic CarcinomaDr. Weeks isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Soft Tissue SarcomaDr. Weeks isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Weeks isExperienced. Learn about Agranulocytosis.
- Ampullary CancerDr. Weeks isExperienced. Learn about Ampullary Cancer.
- Anaplastic Thyroid CancerDr. Weeks isExperienced. Learn about Anaplastic Thyroid Cancer.
- Antiphospholipid SyndromeDr. Weeks isExperienced. Learn about Antiphospholipid Syndrome.